What is the recommended dose of amitriptyline for migraine prophylaxis in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amitriptyline Dosing for Migraine Prophylaxis

For migraine prophylaxis in adults, start amitriptyline at 10-25 mg at bedtime and titrate to a target dose of 25-50 mg daily, with a maximum effective range of 75-150 mg daily if needed. 1

Starting Dose

  • Begin with 10-25 mg at bedtime to minimize side effects and improve tolerability 1
  • The most common starting dose in clinical practice is 10 mg daily, which has been shown to be effective and well-tolerated 2
  • Dosing at night utilizes the sedative effect to improve sleep, which is particularly beneficial for migraine patients 1

Target Therapeutic Dose

  • The effective dose for most patients is 25-50 mg daily 1
  • Clinical trials demonstrating efficacy have used doses between 25-150 mg daily 1
  • Real-world evidence shows that 58% of patients achieve benefit at doses of 10-25 mg, lower than traditional trial doses 2

Titration Schedule

  • Increase the dose slowly by 10-25 mg increments every 2 weeks until therapeutic benefit is achieved or side effects limit further increases 3
  • The goal is to reach 75-150 mg daily or 1-1.5 mg/kg at bedtime for optimal prophylaxis 3
  • Slower titration improves tolerability and medication persistence 3

Duration Before Assessing Efficacy

  • Clinical benefits may take 2-3 months to fully develop, so adequate trial duration is essential 1, 3
  • Do not discontinue therapy before 8 weeks (minimum) to 12 weeks (optimal) unless intolerable side effects occur 1
  • After achieving stability for several months, consider tapering or discontinuing to assess ongoing need 3

Indications for Use

Amitriptyline prophylaxis is indicated when patients have: 1, 3

  • ≥2 migraine attacks per month producing disability lasting ≥3 days per month
  • Use of acute medications more than twice per week
  • Failure of or contraindications to acute migraine treatments
  • Presence of uncommon migraine conditions (prolonged aura, hemiplegic migraine)

Comparative Efficacy

  • Amitriptyline is the only antidepressant with consistent evidence supporting efficacy in migraine prevention 1
  • It appears superior to propranolol for patients with mixed migraine and tension-type headache 3, 4
  • Amitriptyline is equivalent to topiramate in reducing migraine frequency but differs in side effect profile (weight gain vs. weight loss) 5

Common Side Effects to Monitor

  • Anticholinergic effects: dry mouth, constipation, urinary hesitancy, blurred vision 3
  • Sedation and drowsiness: most common, reported in 11% of patients 2
  • Weight gain: average 2.4 kg gain reported in comparative trials 5
  • Prolonged QTc on ECG: requires baseline ECG in at-risk patients 3

Critical Pitfalls to Avoid

  • Do not use amitriptyline as acute treatment—it is strictly a preventive medication 1
  • Do not discontinue before 8-12 weeks unless side effects are intolerable, as benefits develop slowly 1
  • Do not start at high doses—this increases side effects and reduces medication persistence 2
  • Do not overlook that low doses (10-25 mg) are often effective in real-world practice, despite higher doses used in clinical trials 2

Special Populations

  • In children with frequent headaches, use 1 mg/kg per day as the target dose, which has shown 84% improvement rates with minimal side effects 6
  • For chronic daily headache (≥17 headache days per month), amitriptyline shows superior efficacy to placebo with 46% achieving ≥50% improvement at 16 weeks 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.